EDAP TMS S.A. First Quarter 2004 Meets Expectations
April 19 2004 - 12:57PM
PR Newswire (US)
EDAP TMS S.A. First Quarter 2004 Meets Expectations - Improved
Revenues and Restructured Costs Deliver Results - VAULX-EN-VELIN,
France, April 19 /PRNewswire-FirstCall/ -- EDAP TMS S.A. , a global
leader in the development, marketing and distribution of a
portfolio of minimally-invasive medical devices for the treatment
of urological diseases, ahead of the release of its first quarter
2004 financial results on May 12, 2004, today announced progress on
its expectations. The Company's expectations of the first quarter
were based on double digit percentage revenue growth, sustained
gross margins and significant expense reductions, versus same
quarter a year ago, with the aim of operating income or break-even
in each of the two operating divisions. Full first quarter 2004
financial results will be released, as previously announced, on May
12, 2004, followed by a conference call on May 13, 2004. EDAP TMS
S.A. is the global leader in the development, production, marketing
and distribution of a portfolio of minimally invasive medical
devices primarily for the treatment of urological diseases. The
Company currently develops and markets devices for the minimally
invasive treatment of localized prostate cancer, using High
Intensity Focused Ultrasound (HIFU), through its EDAP SA
subsidiary; it is also developing this technology for the treatment
of certain other types of tumors. EDAP TMS S.A. also produces and
commercializes medical equipment for treatment of urinary tract
stones using Extra-corporeal Shockwave Lithotripsy (ESWL), via its
TMS SA subsidiary. In addition, the Company markets in Japan and
Italy devices for the non-surgical treatment of benign Prostate
Hyperplasia (BPH) using Microwave Thermotherapy (TUMT). For more
information, in the U.S., contact EDAP Technomed Inc., the
Company's U.S. subsidiary located in Atlanta, GA, by phone at (770)
446-9950. For additional information on the Company, please see the
Company's web site at: http://www.edap-tms.com/. This press release
contains, in addition to historical information, forward-looking
statements that involve risks and uncertainties. These include
statements regarding the Company's growth and expansion plans. Such
statements are based on management's current expectations and are
subject to a number of uncertainties and risks that could cause
actual results to differ materially from those described in the
forward-looking statements. Factors that may cause such a
difference include, but are not limited to, those described in the
Company's filings with the Securities and Exchange Commission.
CONTACT: Philippe Chauveau / Blandine Confort 33.4.72.15.31.50 Ian
Vawter - EDAP Technomed Inc. 1.770.446.9950 DATASOURCE: EDAP TMS
S.A. CONTACT: Philippe Chauveau or Blandine Confort,
+33-4-72-15-31-50, both for EDAP TMS S.A.; or Ian Vawter - EDAP
Technomed Inc., +1-770-446-9950 Web site: http://www.edap-tms.com/
Copyright
EDAP TMS (NASDAQ:EDAP)
Historical Stock Chart
From Sep 2024 to Oct 2024
EDAP TMS (NASDAQ:EDAP)
Historical Stock Chart
From Oct 2023 to Oct 2024